GNLX Competitors & Alternatives
Compare Genelux Corporation Common Stock with similar stocks in the same industry
Biotechnology
GNLX
Main Stock$2.72
Tradestie Score
63
Market Cap
$166.20M
Revenue Growth
-1.0%
Analyst Upside
+543.4%
Top Competitors
241 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$19.83
|
$170.45M | - | 42 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$7.99
|
$158.43M | - | 32 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$23.56
|
$154.27M | - | 40 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$17.28
|
$133.50M | - | 33 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$23.99
|
$117.07M | - | 31 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.53
|
$114.01M | - | 46 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$34.28
|
$110.20M | - | 34 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.80
|
$97.42M | - | 44 | Compare |
|
PRLD
Prelude Therapeutics Incorporated
|
$6.63
|
$85.47M | - | 43 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.23
|
$84.52M | - | 45 | Compare |
More GNLX Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
241 stocks in this industry